Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours Β· Estimated delivery Oct 9 - Oct 14
The positive announcement had been expected since October, when Novo announced it was ending the FLOW trial early because an interim data analysis showed the drug was surpassing the studys goals
MT-I is a synthetic analog of alpha-melanocyte-stimulating hormone (-MSH), a natural signaling peptide involved in pigmentation
Semaglutide and testosterone are two medications gaining significant attention for their respective benefits
Generally well tolerated in human studies
Product Specifications AOD-9604 Peptide Quality Documentation and Lot Testing HPLC Purity Verification (99%) Chromatographic purity for each lot is measured by reverse-phase HPLC at 220 nm, with the release threshold locked at 99.0% area integration
